DE69710732T2 - Ciclosporin formulierung - Google Patents

Ciclosporin formulierung

Info

Publication number
DE69710732T2
DE69710732T2 DE69710732T DE69710732T DE69710732T2 DE 69710732 T2 DE69710732 T2 DE 69710732T2 DE 69710732 T DE69710732 T DE 69710732T DE 69710732 T DE69710732 T DE 69710732T DE 69710732 T2 DE69710732 T2 DE 69710732T2
Authority
DE
Germany
Prior art keywords
pct
sec
date
pub
ciclosporin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69710732T
Other languages
English (en)
Other versions
DE69710732D1 (de
Inventor
Milan Stuchlik
Tomas Andrysek
Alexander Jegorov
Ales Husek
Vladimir Matha
Josef Stuchlik
Kvetoslava Benesova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ivax Pharmaceuticals sro
Original Assignee
Ivax CR AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivax CR AS filed Critical Ivax CR AS
Publication of DE69710732D1 publication Critical patent/DE69710732D1/de
Application granted granted Critical
Publication of DE69710732T2 publication Critical patent/DE69710732T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69710732T 1996-08-01 1997-07-31 Ciclosporin formulierung Expired - Lifetime DE69710732T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ19962289A CZ288739B6 (cs) 1996-08-01 1996-08-01 Cyklosporin obsahující léčivé přípravky
PCT/GB1997/002079 WO1998005309A1 (en) 1996-08-01 1997-07-31 Cyclosporin formulation

Publications (2)

Publication Number Publication Date
DE69710732D1 DE69710732D1 (de) 2002-04-04
DE69710732T2 true DE69710732T2 (de) 2002-10-17

Family

ID=5464691

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69710732T Expired - Lifetime DE69710732T2 (de) 1996-08-01 1997-07-31 Ciclosporin formulierung

Country Status (11)

Country Link
US (2) US6106860A (de)
EP (1) EP0917460B1 (de)
KR (1) KR100495417B1 (de)
AT (1) ATE213643T1 (de)
AU (1) AU3777197A (de)
CZ (1) CZ288739B6 (de)
DE (1) DE69710732T2 (de)
DK (1) DK0917460T3 (de)
ES (1) ES2171976T3 (de)
PT (1) PT917460E (de)
WO (1) WO1998005309A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky
SE511313C2 (sv) * 1997-01-13 1999-09-06 Gs Dev Ab Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
GB9811854D0 (en) * 1998-06-02 1998-07-29 Ciba Geigy Ag Organic compounds
AUPP627498A0 (en) 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
ATE437629T1 (de) * 2001-10-19 2009-08-15 Isotechnika Inc Neue cyclosporin-analoge mikroemulsionsvorkonzentrate
GB2391473B (en) * 2002-08-02 2004-07-07 Satishchandra Punambhai Patel Pharmaceutical compositions
US7851444B2 (en) 2002-12-02 2010-12-14 Xenome Ltd. χ-conotoxin peptides (-1)
EP2386566A3 (de) 2002-12-02 2012-02-15 Xenome Ltd Chi-Conotoxin-Peptide (II)
KR100884189B1 (ko) * 2007-06-20 2009-02-18 심종원 치아세정수단의 탈부착이 가능한 샤워기

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
CZ288631B6 (cs) * 1996-01-18 2001-08-15 Galena, A. S. Léčivé přípravky s obsahem cyklosporinu
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky

Also Published As

Publication number Publication date
ES2171976T3 (es) 2002-09-16
US6312721B1 (en) 2001-11-06
PT917460E (pt) 2002-07-31
EP0917460A1 (de) 1999-05-26
CZ288739B6 (cs) 2001-08-15
KR100495417B1 (ko) 2005-06-14
EP0917460B1 (de) 2002-02-27
DE69710732D1 (de) 2002-04-04
KR20000029746A (ko) 2000-05-25
DK0917460T3 (da) 2002-03-25
CZ228996A3 (cs) 1998-02-18
ATE213643T1 (de) 2002-03-15
WO1998005309A1 (en) 1998-02-12
AU3777197A (en) 1998-02-25
US6106860A (en) 2000-08-22

Similar Documents

Publication Publication Date Title
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
HK1036931A1 (en) Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients.
ATE387430T1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
TNSN00010A1 (fr) DIPHENYLUREE A SUBSTITUTION ω CARBOXYARYLE SERVANT D'INHIBUTEURS DE RAF KINASE.
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
EA200100519A1 (ru) Композиции на основе тонкоизмельченного эплеренона
DE60021179D1 (de) Hautpflegemitteln enthaltend eine kombination von aktive wirkstoffen
PL347671A1 (en) Compounds and compositions for delivering active agents
MA26458A1 (fr) Nouveaux derives cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent.
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
IL140710A0 (en) Pulmonary delivery of active agents
GEP20002211B (en) Taxoids, Preparation Thereof, Pharmaceutical Compositions Containing Same
ATE311373T1 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
EP0828481A4 (de) Orale dosis zur intestinalen verabreichung sowie verfahren zu deren verwendung
ATE396967T1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
FI964285A (fi) Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet
DE69710732D1 (de) Ciclosporin formulierung
SE9801495D0 (sv) Protein formulationa
ATE179164T1 (de) Hiv-proteaseinhibitoren
UA74388C2 (uk) Фармацевтичні композиції тизоксаніду і нітазоксаніду
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
EP0820770A3 (de) Arzneimittel zur Behandlung von Neuropathien, das ein lipidlösliches Thiamin und ein Antioxidans enthält
DE3850044D1 (de) Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: IVAX PHARMACEUTICALS S.R.O., OPAVA, CZ